CD4 and tuberculosis: Finally, a study conducted in Ethiopia randomized the initiation of ART to one week, four weeks, and eight weeks in patients with a baseline CD4 count of < 200 (median CD4 = 73), found that ART at one week after TB treatment didn’t improve overall survival compared to 4 and 8 weeks.